Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD
Clinical trial NCT03834766 · COMPLETED
Trial details
- NCT number
- NCT03834766
- Sponsor
- Tris Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-06
- Primary completion
- 2019-10-19
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.